Felipe Pérez‐García
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research 9
- COVID-19 Clinical Research Studies 9
- SARS-CoV-2 detection and testing 6
-
- Hepatitis C virus research 5
-
- Respiratory viral infections research 5
- Sepsis Diagnosis and Treatment 4
- Hepatitis B Virus Studies 4
-
- Long-Term Effects of COVID-19 5
- Co-authors
- Juan Cuadros‐GonzálezRamón Pérez‐TanoiraJuan RomanykTeresa ArroyoPeña Gómez-HerruzEmilio BouzaManuel LinaresAna Carrero
- Journals
- The Journal of Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- SpainUnited StatesNetherlands
In The Last Decade
Felipe Pérez‐García
33 papers receiving 576 citations
Peers
Comparison fields: 5 of 75
- Infectious Diseases 386
- Hepatology 45
- Epidemiology 190
- Virology 16
- General Dentistry 6
Countries citing papers authored by Felipe Pérez‐García
This map shows the geographic impact of Felipe Pérez‐García's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Pérez‐García with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Pérez‐García more than expected).
Fields of papers citing papers by Felipe Pérez‐García
This network shows the impact of papers produced by Felipe Pérez‐García. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Pérez‐García. The network helps show where Felipe Pérez‐García may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Felipe Pérez‐García, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 56 | |
| 7 | 2022 | 17 | |
| 8 | SARS-CoV-2 seroprevalence among workers in a hospital in Madrid | 2021 | 4 |
| 9 | 2021 | 19 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 8 | |
| 13 | 2020 | 11 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 17 | |
| 16 | 2018 | 14 | |
| 17 | 2018 | 19 | |
| 18 | 2018 | 12 | |
| 19 | 2017 | 19 | |
| 20 | 1996 | 31 |
About Felipe Pérez‐García
Felipe Pérez‐García is a scholar working on Infectious Diseases, Hepatology and Epidemiology, having authored 35 papers that have together received 587 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (9 papers), COVID-19 Clinical Research Studies (9 papers), SARS-CoV-2 detection and testing (6 papers), Respiratory viral infections research (5 papers), Hepatitis C virus research (5 papers), Long-Term Effects of COVID-19 (5 papers), Sepsis Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Infectious Diseases (386 citations), Hepatology (45 citations) and Epidemiology (190 citations). Felipe Pérez‐García has collaborated with scholars based in Spain, United States and Netherlands. Frequent co-authors include Juan Cuadros‐González, Ramón Pérez‐Tanoira, Juan Romanyk, Teresa Arroyo, Peña Gómez-Herruz, Emilio Bouza, Manuel Linares, Ana Carrero, Roberto Alonso and Salvador Resino. Their work appears in journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.